SCHEMBL17267229

CO[C@H]1O[C@H](C(=O)O)[C@H](O[C@H]2OC(C(=O)O)[C@H](O[C@H]3O[C@H](C(=O)O)[C@H](O[C@H]4OC(C(=O)O)[C@H](O[C@H]5O[C@H](C(=O)O)[C@H](O[C@H]6OC(C(=O)O)[C@H](OC)[C@@H](O)C6O)C(O)C5C)[C@@H](O)C4O)C(O)C3C)[C@@H](O)C2O)C(O)C1C

nearest known ligand 0.40

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	F10	P00742	6/20	0.40

▸	CXCL10	P02778	1/20	0.36

▸	CXCL8	P10145	1/20	0.36

▸	CCL2	P13500	1/20	0.36

▸	CCL5	P13501	1/20	0.36

▸	CXCL12	P48061	1/20	0.36

▸	SERPINC1	P01008	2/20	0.34

▸	M6PR	P20645	1/20	0.34

▸	FGF1	P05230	3/20	0.34

▸	BDNF	P23560	3/20	0.33

▸	PTN	P21246	2/20	0.33

▸	MDK	P21741	2/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL17830304	0.99	F10 (0.41)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL12384884	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL20370858	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL18309852	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL12458629	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL12878540	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL20363815	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL12755226	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL22139521	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5
SCHEMBL20363547	0.90	F10 (0.43)	F10CXCL10CXCL8CCL2CCL5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20150328122-A1	Personal Care Composition and Methods of Making the Same	KERACOL LIMITED (GB)	2015-11-19	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20150328122-A1	Personal Care Composition and Methods of Making the Same	POLR1C, CUTA, KRT18	F10 403/4885CXCL10 1277/4885CXCL8 4497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.